SCHEMBL2830069

SCHEMBL2830069

COc1ccc(-c2csc(N(CCN3CCOCC3)C(=O)c3cccs3)n2)cc1OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.54
MAPK1 P28482 3/20 0.54
LMNA P02545 3/20 0.54
ALDH1A1 P00352 6/20 0.53
KDM4E B2RXH2 6/20 0.53
NPC1 O15118 4/20 0.53
RAB9A P51151 3/20 0.53
TDP1 Q9NUW8 1/20 0.53
TSHR P16473 9/20 0.53
OPRM1 P35372 1/20 0.53
OPRD1 P41143 1/20 0.53
SMN1; SMN2 Q16637 5/20 0.52
NPSR1 Q6W5P4 3/20 0.51
USP2 O75604 2/20 0.50
HPGD P15428 2/20 0.48
HSD17B10 Q99714 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2830237 0.95 MAPT (0.60) MAPTMAPK1LMNAALDH1A1KDM4E
SCHEMBL2829972 0.94 MAPT (0.57) MAPTMAPK1LMNAALDH1A1KDM4E
SCHEMBL2830285 0.88 TSHR (0.58) MAPTMAPK1LMNAALDH1A1KDM4E
SCHEMBL2830435 0.87 TSHR (0.57) MAPTMAPK1LMNAALDH1A1KDM4E
SCHEMBL2830037 0.84 MAPT (0.74) MAPTMAPK1LMNAALDH1A1KDM4E
SCHEMBL2830852 0.84 MAPT (0.62) MAPTMAPK1LMNAALDH1A1KDM4E
SCHEMBL2829419 0.84 MAPT (0.62) MAPTMAPK1LMNAALDH1A1KDM4E
SCHEMBL2830079 0.83 TSHR (0.63) MAPTMAPK1LMNAALDH1A1KDM4E
SCHEMBL2828579 0.82 MAPT (0.60) MAPTMAPK1LMNAALDH1A1KDM4E
SCHEMBL2827593 0.82 MAPT (0.56) MAPTMAPK1LMNAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795290-B2 2-amido-thiazole-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof GENENTECH, INC. (US) 2010-09-14 US claimed
EP-2168578-A2 2-Amido-Thiazole-Based Compounds Exhibiting ATP-Utilizing Enzyme Inhibitory Activity, and Compositions, and Uses Thereof Genentech, Inc. (US) 2010-03-31 EP claimed
US-20090048313-A1 2-AMIDO-THIAZOLE-BASED COMPOUNDS EXHIBITING ATP-UTILIZING ENZYME INHIBITORY ACTIVITY, AND COMPOSITIONS, AND USES THEREOF GENENTECH, INC. (US) 2009-02-19 US claimed
US-7410988-B2 2-Amido-thiazole-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof GENENTECH, INC. (US) 2008-08-12 US claimed
EP-2620150-A2 2-Amido Thiazole Based Inhibitors of ATP-Utilizing Enyzmes Genentech, Inc. (US) 2013-07-31 EP disclosed
EP-2168578-A2 2-Amido-Thiazole-Based Compounds Exhibiting ATP-Utilizing Enzyme Inhibitory Activity, and Compositions, and Uses Thereof Genentech, Inc. (US) 2010-03-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090048313-A1 2-AMIDO-THIAZOLE-BASED COMPOUNDS EXHIBITING ATP-UTILIZING ENZYME INHIBITORY ACTIVITY, AND COMPOSITIONS, AND USES THEREOF ATP5ME, ATP5MG, ATP5MK MAPT 3561/4885MAPK1 3940/4885LMNA 4104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.